Insights

Strategic market Phoreus Biotechnology operates in the biotechnology research sector with a proprietary BAPC technology platform targeting vaccines, cancer therapies, antibiotics and biopesticides, indicating multiple potential cross-sell opportunities across human, animal, plant and environmental health markets.

Growth potential Revenue range and recent funding suggest a growth trajectory with room for partnerships and pilot collaborations to accelerate adoption of BAPC based solutions in near-term projects.

Recent wins Award recognitions and a successful peptide transfection reagent launch indicate proven product-market fit and a track record that can be leveraged to pursue enterprise customers, research institutes, and contract development organizations.

Strategic partnerships Collaborations or co-development opportunities with vaccine developers, agricultural biotech firms and animal health companies could scale delivery system capabilities, expand addressable markets, and accelerate go-to-market timelines.

Digital readiness A modern tech stack with cloud, analytics, and e-commerce capabilities suggests readiness to engage customers digitally, run targeted campaigns, and streamline licensing, partnerships, or pilot program procurement.

Similar companies to Phoreus Biotechnology, Inc.

Phoreus Biotechnology, Inc. Tech Stack

Phoreus Biotechnology, Inc. uses 8 technology products and services including HubSpot Analytics, WordPress, Cookiebot, and more. Explore Phoreus Biotechnology, Inc.'s tech stack below.

Media & News

Phoreus Biotechnology, Inc.'s Email Address Formats

Phoreus Biotechnology, Inc. uses at least 3 email formats:
Phoreus Biotechnology, Inc. Email FormatsExamplePercentage
First.Last@phoreusbiotech.comJohn.Doe@phoreusbiotech.com
77%
Last@phoreusbiotech.comDoe@phoreusbiotech.com
15%
First@phoreusbiotech.comJohn@phoreusbiotech.com
8%

Frequently Asked Questions

What is Phoreus Biotechnology, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Phoreus Biotechnology, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Phoreus Biotechnology, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Phoreus Biotechnology, Inc.'s official website is phoreusbiotech.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Phoreus Biotechnology, Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, Phoreus Biotechnology, Inc.'s annual revenue is estimated to be $10M - $25M.

What is Phoreus Biotechnology, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Phoreus Biotechnology, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Phoreus Biotechnology, Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, Phoreus Biotechnology, Inc. has approximately 13 employees across 1 continents, including North America. Key team members include Director Of Marketing And Business Development: B. T. Explore Phoreus Biotechnology, Inc.'s employee directory with LeadIQ.

What industry does Phoreus Biotechnology, Inc. belong to?

Minus sign iconPlus sign icon
Phoreus Biotechnology, Inc. operates in the Biotechnology Research industry.

What technology does Phoreus Biotechnology, Inc. use?

Minus sign iconPlus sign icon
Phoreus Biotechnology, Inc.'s tech stack includes HubSpot Analytics, WordPress, Cookiebot, WooCommerce, Microsoft 365, Google Cloud, WP Engine and Piwik.

What is Phoreus Biotechnology, Inc.'s email format?

Minus sign iconPlus sign icon
Phoreus Biotechnology, Inc.'s email format typically follows the pattern of First.Last@phoreusbiotech.com. Find more Phoreus Biotechnology, Inc. email formats with LeadIQ.

How much funding has Phoreus Biotechnology, Inc. raised to date?

Minus sign iconPlus sign icon
As of November 2026, Phoreus Biotechnology, Inc. has raised $5.3M in funding. The last funding round occurred on May 11, 2022 for $2.3M.

When was Phoreus Biotechnology, Inc. founded?

Minus sign iconPlus sign icon
Phoreus Biotechnology, Inc. was founded in 2018.
Phoreus Biotechnology, Inc. logo

Phoreus Biotechnology, Inc.

Biotechnology ResearchKansas, United States11-50 Employees

Phoreus Biotechnology, Inc. is a biotechnology research company based in Olathe, Kansas, focused on a proprietary delivery platform built around Branched Amphipathic Peptide Capsules (BAPC). The platform is designed to enhance the creation and delivery of vaccines, cancer therapies, alternative antibiotics, and biopesticides, with the goal of improving human, animal, plant, and environmental health.

Its customers are researchers and developers seeking more effective, safer delivery systems for biologics and related therapeutics within the One Health framework. In 2021, the company announced the appointment of Steve Schram as chief executive officer and earned industry recognition for its work in animal health innovation. With a small-to-mid sized team and a focus on next-generation peptide nanocarriers, Phoreus Biotechnology positions itself within the biotechnology research sector addressing cross-species health applications.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $5.3M

    Phoreus Biotechnology, Inc. has raised a total of $5.3M of funding over 2 rounds. Their latest funding round was raised on May 11, 2022 in the amount of $2.3M as a Seed.

  • $10M - $25M

    Phoreus Biotechnology, Inc.'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.